Vertex Pharma scientist talks about the long road to developing non
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles
Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal by a Canadian-born former Guantanam2024-05-21Former Jets offensive tackle Mekhi Becton agrees to 1
Former New York Jets offensive tackle Mekhi Becton has agreed to terms with the Philadelphia Eagles2024-05-21China's top liquor brand reports 15.59 pct profit surge in Q1
GUIYANG, April 27 (Xinhua) -- Kweichow Moutai, China's leading liquor maker, earned profits of 33.22024-05-21Girona close in on UCL sopt with Las Palmas win
Girona moved above FC Barcelona to second place in LaLiga with a 2-0 win away to Las Palmas on Satur2024-05-21College baseball notebook: Conference tournaments to decide NCAA automatic bids and many at
The field for the NCAA baseball tournament will take shape this week with conference tournaments det2024-05-21Winning farewell for China at U23 Asian Cup
China beat the United Arab Emirates 2-1 in their final group match at the U23 Asian Cup on Monday, e2024-05-21
atest comment